Regeneron Pharmaceuticals, Inc.
$790.74
-5.60 (-0.70%)
Price as of Oct 16, 2026 market close
Performance
- 1 Month
- +0.2%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Largest decline max drawdown, since Aug 2026
- -14.7%
Own REGN?
See how REGN contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.